Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanni Shen

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 24, 2023
Identification of Andrographolide as a novel FABP4 inhibitor for osteoarthritis treatmentKuangyang Yang, Qian Xie, Jianhui Liang, et al.
Nature Communications|May 13, 2025
FABP4 inhibition suppresses bone resorption and protects against postmenopausal osteoporosis in ovariectomized miceQian Xie, Xiangfu Du, Jianhui Liang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 20, 2022
Astragaloside IV as a novel CXCR4 antagonist alleviates osteoarthritis in the knee of monosodium iodoacetate-induced ratsKuangyang Yang, Qian Xie, Tingting Tang, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 24, 2023
Identification of Andrographolide as a novel FABP4 inhibitor for osteoarthritis treatmentKuangyang Yang, Qian Xie, Jianhui Liang, et al.
Nature Communications|May 13, 2025
FABP4 inhibition suppresses bone resorption and protects against postmenopausal osteoporosis in ovariectomized miceQian Xie, Xiangfu Du, Jianhui Liang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 20, 2022
Astragaloside IV as a novel CXCR4 antagonist alleviates osteoarthritis in the knee of monosodium iodoacetate-induced ratsKuangyang Yang, Qian Xie, Tingting Tang, et al.
Pageof 2